| |
 |
 |
|
| |
Address:
377 Saw Creek Estates,
Bushkill, PA18324, USA
Tel: +1 570-588-3854
Fax: +1 702-995-3905
+1 570-588-3213
Email:
info@pharmachinaonline.com |
| |
|
|
| Title: |
China Medical System Holdings to initiate phase II trial of new lung cancer drug (2008) |
| Type： |
Pharmaceutical Chemical(NCE) |
| Status： |
Phase Ⅱ |
Targeted
Indication(s): |
non-small cell lung cancer |
| Developer(s): |
China Medical System Holdings Ltd. |
Description
/Summary： |
China Medical System Holdings Ltd. said it had received approval from the Chinese State Food and Drug Administration (SFDA) to begin the Phase II clinical trial for CMS024-02 (Tyroservatide), a drug for the treatment of non-small cell lung cancer.
|
Additional
Info/Comments: |
The company said it plans to initiate the Phase II Clinical Trial Protocol in the second half of 2008. |
|
|
